Encavis Valuation
Is 0NBT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0NBT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 0NBT's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 0NBT's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0NBT?
Key metric: As 0NBT is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 0NBT's PS Ratio? | |
|---|---|
| PS Ratio | 6.1x |
| Sales | €457.94m |
| Market Cap | €2.80b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 10.5x |
| Enterprise Value/EBITDA | 18.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0NBT's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.8x | ||
DRX Drax Group | 0.3x | -8.6% | UK£2.4b |
PNN Pennon Group | 1.9x | 8.0% | UK£1.7b |
CNA Centrica | 0.3x | -4.2% | UK£6.4b |
TEP Telecom Plus | 0.8x | 8.1% | UK£1.4b |
0NBT Encavis | 6.1x | 8.4% | €2.8b |
Price-To-Sales vs Peers: 0NBT is expensive based on its Price-To-Sales Ratio (6.1x) compared to the peer average (0.8x).
Price to Sales Ratio vs Industry
How does 0NBT's PS Ratio compare vs other companies in the European Renewable Energy Industry?
| 13 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 13 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: 0NBT is expensive based on its Price-To-Sales Ratio (6.1x) compared to the European Renewable Energy industry average (2.6x).
Price to Sales Ratio vs Fair Ratio
What is 0NBT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 6.1x |
| Fair PS Ratio | 4.3x |
Price-To-Sales vs Fair Ratio: 0NBT is expensive based on its Price-To-Sales Ratio (6.1x) compared to the estimated Fair Price-To-Sales Ratio (4.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €17.27 | €17.87 +3.5% | 4.9% | €20.30 | €17.50 | n/a | 9 |
| Nov ’25 | €17.12 | €17.87 +4.4% | 4.9% | €20.30 | €17.50 | n/a | 9 |
| Oct ’25 | €17.11 | €17.47 +2.1% | 7.9% | €20.30 | €13.90 | n/a | 11 |
| Sep ’25 | €17.03 | €17.47 +2.6% | 7.9% | €20.30 | €13.90 | n/a | 11 |
| Aug ’25 | €17.07 | €17.47 +2.4% | 7.9% | €20.30 | €13.90 | n/a | 11 |
| Jul ’25 | €16.90 | €17.47 +3.4% | 7.9% | €20.30 | €13.90 | n/a | 11 |
| Jun ’25 | €17.08 | €17.48 +2.3% | 7.6% | €20.30 | €13.90 | n/a | 12 |
| May ’25 | €16.91 | €17.60 +4.1% | 7.9% | €20.30 | €13.90 | n/a | 12 |
| Apr ’25 | €16.86 | €17.68 +4.9% | 8.1% | €20.30 | €13.90 | n/a | 12 |
| Mar ’25 | €11.06 | €17.69 +60.0% | 28.0% | €28.00 | €11.50 | n/a | 12 |
| Feb ’25 | €12.90 | €18.69 +44.9% | 25.6% | €28.00 | €11.50 | n/a | 12 |
| Jan ’25 | €15.45 | €19.25 +24.6% | 22.2% | €28.00 | €12.00 | n/a | 12 |
| Dec ’24 | €13.87 | €19.25 +38.8% | 22.2% | €28.00 | €12.00 | n/a | 12 |
| Nov ’24 | €12.11 | €20.82 +71.9% | 20.3% | €28.00 | €12.00 | €17.12 | 11 |
| Oct ’24 | €13.42 | €21.70 +61.8% | 15.4% | €28.00 | €17.00 | €17.11 | 10 |
| Sep ’24 | €13.91 | €21.96 +57.9% | 15.2% | €28.00 | €17.00 | €17.03 | 11 |
| Aug ’24 | €15.26 | €22.05 +44.6% | 14.8% | €28.00 | €17.00 | €17.07 | 11 |
| Jul ’24 | €14.99 | €22.33 +48.9% | 14.3% | €28.00 | €17.00 | €16.90 | 11 |
| Jun ’24 | €15.22 | €22.33 +46.7% | 14.3% | €28.00 | €17.00 | €17.08 | 11 |
| May ’24 | €15.71 | €22.41 +42.6% | 14.1% | €28.00 | €17.00 | €16.91 | 11 |
| Apr ’24 | €15.60 | €22.38 +43.4% | 14.2% | €28.00 | €17.00 | €16.86 | 11 |
| Mar ’24 | €17.77 | €22.72 +27.9% | 15.7% | €28.00 | €17.00 | €11.06 | 10 |
| Feb ’24 | €17.99 | €22.42 +24.7% | 16.6% | €28.00 | €17.00 | €12.90 | 9 |
| Jan ’24 | €18.61 | €23.73 +27.5% | 13.7% | €28.60 | €19.00 | €15.45 | 9 |
| Dec ’23 | €20.20 | €24.18 +19.7% | 15.6% | €30.00 | €19.00 | €13.87 | 9 |
| Nov ’23 | €19.19 | €24.11 +25.6% | 14.9% | €30.00 | €19.00 | €12.11 | 10 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Pennon Group
UK£1.7b
Provides water and wastewater services for household and non-household customers in the United Kingdom.
PNNL
UK£5.84
7D
2.3%
1Y
-22.1%
EVN
€4.4b
Provides energy and environmental services for private and business customers, and municipalities.
0EEI
€24.60
7D
0.2%
1Y
-8.4%
GAIL (India)
₹1.3t
Operates as a natural gas processing and distribution company in India and internationally.
GAID
₹13.60
7D
3.0%
1Y
50.3%